Instead, we observed that two CD147 blocking mAbs at a concentration of 20 μg/ml mildly hindered SARS-CoV-2 infection of ACE2+ Caco-2 cells, while they significantly reduced infection of ACE2- human monocytes. This evidence concerns the gene BSG and infection.